(AMAT) Applied Materials - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0382221051
Stock: Semiconductor Capital Equipment, Deposition, Etch, Metrology, Wafer Packaging
Total Rating 76
Risk 89
Buy Signal -0.02
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.02% |
| Yield on Cost 5y | 2.20% |
| Yield CAGR 5y | 17.31% |
| Payout Consistency | 99.1% |
| Payout Ratio | 19.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 45.9% |
| Relative Tail Risk | -7.85% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.28 |
| Alpha | 51.74 |
| Character TTM | |
|---|---|
| Beta | 1.639 |
| Beta Downside | 1.368 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.88% |
| CAGR/Max DD | 0.79 |
Description: AMAT Applied Materials January 28, 2026
Applied Materials (NASDAQ: AMAT) delivers materials-engineering equipment, services, and software to semiconductor manufacturers worldwide, operating through two segments: Semiconductor Systems, which supplies capital-equipment for etch, deposition, rapid thermal processing, CMP, metrology, inspection, packaging and ion implantation; and Applied Global Services (AGS), which provides spares, upgrades, automation software and 200-mm tool support to boost fab productivity. The firm serves a global client base across the United States, China, Korea, Taiwan, Japan, Southeast Asia and Europe.
Key recent metrics (Q4 2023 / FY 2023): Revenue $5.9 billion in the quarter, $25.4 billion for the year (+9 % YoY); operating margin 18 %; capital-expenditure guidance of roughly $5 billion for 2024, reflecting strong AI-driven demand for advanced nodes. Approximately 15 % of revenue is derived from China, making geopolitical policy a material risk factor. The broader semiconductor equipment sector is expanding at a 7-8 % CAGR through 2027, driven by rising demand for high-performance computing and automotive electronics.
For a deeper quantitative view, you might explore ValueRay’s detailed valuation models to assess how these drivers could affect AMAT’s upside potential.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 7.00b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA -6.06 > 1.0 |
| NWC/Revenue: 45.41% < 20% (prev 46.92%; Δ -1.51% < -1%) |
| CFO/TA 0.22 > 3% & CFO 7.96b > Net Income 7.00b |
| Net Debt (-191.0m) to EBITDA (9.65b): -0.02 < 3 |
| Current Ratio: 2.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (798.0m) vs 12m ago -3.62% < -2% |
| Gross Margin: 48.67% > 18% (prev 0.47%; Δ 4820 % > 0.5%) |
| Asset Turnover: 80.24% > 50% (prev 78.98%; Δ 1.26% > 0%) |
| Interest Coverage Ratio: 35.46 > 6 (EBITDA TTM 9.65b / Interest Expense TTM 269.0m) |
Altman Z'' 10.00
| A: 0.35 (Total Current Assets 20.88b - Total Current Liabilities 8.00b) / Total Assets 36.30b |
| B: 1.52 (Retained Earnings 55.23b / Total Assets 36.30b) |
| C: 0.27 (EBIT TTM 9.54b / Avg Total Assets 35.35b) |
| D: 3.47 (Book Value of Equity 55.12b / Total Liabilities 15.88b) |
| Altman-Z'' Score: 12.75 = AAA |
Beneish M -3.06
| DSRI: 0.95 (Receivables 5.33b/5.35b, Revenue 28.37b/27.18b) |
| GMI: 0.97 (GM 48.67% / 47.46%) |
| AQI: 1.03 (AQ_t 0.28 / AQ_t-1 0.28) |
| SGI: 1.04 (Revenue 28.37b / 27.18b) |
| TATA: -0.03 (NI 7.00b - CFO 7.96b) / TA 36.30b) |
| Beneish M-Score: -3.06 (Cap -4..+1) = AA |
What is the price of AMAT shares?
As of February 07, 2026, the stock is trading at USD 303.99 with a total of 8,512,158 shares traded.
Over the past week, the price has changed by -10.94%, over one month by +6.92%, over three months by +26.44% and over the past year by +69.94%.
Over the past week, the price has changed by -10.94%, over one month by +6.92%, over three months by +26.44% and over the past year by +69.94%.
Is AMAT a buy, sell or hold?
Applied Materials has received a consensus analysts rating of 4.21.
Therefore, it is recommended to buy AMAT.
- StrongBuy: 21
- Buy: 6
- Hold: 10
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the AMAT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 317.6 | 4.5% |
| Analysts Target Price | 317.6 | 4.5% |
| ValueRay Target Price | 415.1 | 36.6% |
AMAT Fundamental Data Overview January 31, 2026
P/E Trailing = 39.3702
P/E Forward = 35.461
P/S = 9.5505
P/B = 13.2711
P/EG = 2.8803
Revenue TTM = 28.37b USD
EBIT TTM = 9.54b USD
EBITDA TTM = 9.65b USD
Long Term Debt = 6.46b USD (from longTermDebt, last quarter)
Short Term Debt = 191.0m USD (from shortTermDebt, last quarter)
Debt = 7.05b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -191.0m USD (from netDebt column, last quarter)
Enterprise Value = 269.41b USD (270.93b + Debt 7.05b - CCE 8.57b)
Interest Coverage Ratio = 35.46 (Ebit TTM 9.54b / Interest Expense TTM 269.0m)
EV/FCF = 47.28x (Enterprise Value 269.41b / FCF TTM 5.70b)
FCF Yield = 2.12% (FCF TTM 5.70b / Enterprise Value 269.41b)
FCF Margin = 20.09% (FCF TTM 5.70b / Revenue TTM 28.37b)
Net Margin = 24.67% (Net Income TTM 7.00b / Revenue TTM 28.37b)
Gross Margin = 48.67% ((Revenue TTM 28.37b - Cost of Revenue TTM 14.56b) / Revenue TTM)
Gross Margin QoQ = 48.01% (prev 48.78%)
Tobins Q-Ratio = 7.42 (Enterprise Value 269.41b / Total Assets 36.30b)
Interest Expense / Debt = 1.01% (Interest Expense 71.0m / Debt 7.05b)
Taxrate = 16.32% (370.0m / 2.27b)
NOPAT = 7.98b (EBIT 9.54b * (1 - 16.32%))
Current Ratio = 2.61 (Total Current Assets 20.88b / Total Current Liabilities 8.00b)
Debt / Equity = 0.35 (Debt 7.05b / totalStockholderEquity, last quarter 20.41b)
Debt / EBITDA = -0.02 (Net Debt -191.0m / EBITDA 9.65b)
Debt / FCF = -0.03 (Net Debt -191.0m / FCF TTM 5.70b)
Total Stockholder Equity = 19.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.79% (Net Income 7.00b / Total Assets 36.30b)
RoE = 36.12% (Net Income TTM 7.00b / Total Stockholder Equity 19.38b)
RoCE = 36.93% (EBIT 9.54b / Capital Employed (Equity 19.38b + L.T.Debt 6.46b))
RoIC = 31.05% (NOPAT 7.98b / Invested Capital 25.71b)
WACC = 11.68% (E(270.93b)/V(277.98b) * Re(11.96%) + D(7.05b)/V(277.98b) * Rd(1.01%) * (1-Tc(0.16)))
Discount Rate = 11.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.65%
[DCF Debug] Terminal Value 65.30% ; FCFF base≈6.41b ; Y1≈6.25b ; Y5≈6.27b
Fair Price DCF = 81.88 (EV 64.80b - Net Debt -191.0m = Equity 64.99b / Shares 793.7m; r=11.68% [WACC]; 5y FCF grow -3.69% → 2.90% )
EPS Correlation: 87.89 | EPS CAGR: 3.75% | SUE: 1.11 | # QB: 14
Revenue Correlation: 82.34 | Revenue CAGR: 2.18% | SUE: 0.13 | # QB: 0
EPS next Quarter (2026-04-30): EPS=2.28 | Chg30d=+0.024 | Revisions Net=+6 | Analysts=27
EPS current Year (2026-10-31): EPS=9.67 | Chg30d=+0.159 | Revisions Net=+11 | Growth EPS=+2.6% | Growth Revenue=+2.8%
EPS next Year (2027-10-31): EPS=12.06 | Chg30d=+0.503 | Revisions Net=+12 | Growth EPS=+24.7% | Growth Revenue=+15.3%
P/E Forward = 35.461
P/S = 9.5505
P/B = 13.2711
P/EG = 2.8803
Revenue TTM = 28.37b USD
EBIT TTM = 9.54b USD
EBITDA TTM = 9.65b USD
Long Term Debt = 6.46b USD (from longTermDebt, last quarter)
Short Term Debt = 191.0m USD (from shortTermDebt, last quarter)
Debt = 7.05b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -191.0m USD (from netDebt column, last quarter)
Enterprise Value = 269.41b USD (270.93b + Debt 7.05b - CCE 8.57b)
Interest Coverage Ratio = 35.46 (Ebit TTM 9.54b / Interest Expense TTM 269.0m)
EV/FCF = 47.28x (Enterprise Value 269.41b / FCF TTM 5.70b)
FCF Yield = 2.12% (FCF TTM 5.70b / Enterprise Value 269.41b)
FCF Margin = 20.09% (FCF TTM 5.70b / Revenue TTM 28.37b)
Net Margin = 24.67% (Net Income TTM 7.00b / Revenue TTM 28.37b)
Gross Margin = 48.67% ((Revenue TTM 28.37b - Cost of Revenue TTM 14.56b) / Revenue TTM)
Gross Margin QoQ = 48.01% (prev 48.78%)
Tobins Q-Ratio = 7.42 (Enterprise Value 269.41b / Total Assets 36.30b)
Interest Expense / Debt = 1.01% (Interest Expense 71.0m / Debt 7.05b)
Taxrate = 16.32% (370.0m / 2.27b)
NOPAT = 7.98b (EBIT 9.54b * (1 - 16.32%))
Current Ratio = 2.61 (Total Current Assets 20.88b / Total Current Liabilities 8.00b)
Debt / Equity = 0.35 (Debt 7.05b / totalStockholderEquity, last quarter 20.41b)
Debt / EBITDA = -0.02 (Net Debt -191.0m / EBITDA 9.65b)
Debt / FCF = -0.03 (Net Debt -191.0m / FCF TTM 5.70b)
Total Stockholder Equity = 19.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 19.79% (Net Income 7.00b / Total Assets 36.30b)
RoE = 36.12% (Net Income TTM 7.00b / Total Stockholder Equity 19.38b)
RoCE = 36.93% (EBIT 9.54b / Capital Employed (Equity 19.38b + L.T.Debt 6.46b))
RoIC = 31.05% (NOPAT 7.98b / Invested Capital 25.71b)
WACC = 11.68% (E(270.93b)/V(277.98b) * Re(11.96%) + D(7.05b)/V(277.98b) * Rd(1.01%) * (1-Tc(0.16)))
Discount Rate = 11.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.65%
[DCF Debug] Terminal Value 65.30% ; FCFF base≈6.41b ; Y1≈6.25b ; Y5≈6.27b
Fair Price DCF = 81.88 (EV 64.80b - Net Debt -191.0m = Equity 64.99b / Shares 793.7m; r=11.68% [WACC]; 5y FCF grow -3.69% → 2.90% )
EPS Correlation: 87.89 | EPS CAGR: 3.75% | SUE: 1.11 | # QB: 14
Revenue Correlation: 82.34 | Revenue CAGR: 2.18% | SUE: 0.13 | # QB: 0
EPS next Quarter (2026-04-30): EPS=2.28 | Chg30d=+0.024 | Revisions Net=+6 | Analysts=27
EPS current Year (2026-10-31): EPS=9.67 | Chg30d=+0.159 | Revisions Net=+11 | Growth EPS=+2.6% | Growth Revenue=+2.8%
EPS next Year (2027-10-31): EPS=12.06 | Chg30d=+0.503 | Revisions Net=+12 | Growth EPS=+24.7% | Growth Revenue=+15.3%